http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02245184-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cfc033f059d282fcd915bc8be2ae53f
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
filingDate 1989-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81d1a4638a30958dcd8b487e6e604842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2586045169f048208b4b3fd1310321da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40f02a8f8d3d22442a85ef391bb931ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ca9c55c29e63c948e5bf6b24134c680
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab903c315f02adf9d44a7d7d8d34063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32d60e61126fd664a2de12c72623334e
publicationDate 1990-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02245184-A
titleOfInvention Human monoclonal antibody reactive with b serum-type pseudomonas aeruginosa, cell capable of producing same, its production and pharmaceutical
abstract PURPOSE: To provide human-human hybridoma and cell strain stemmed therefrom, capable of stably producing in relatively large quantities human monoclonal antibody reactive with B serum-type Pseudomonas aeruginosa. n CONSTITUTION: For example, using, as parent cell strain, infinitely reproductive cell strain having only human chromosome and resistant to both 8-azaguanine and ouabain, and using, as human antibody-productive cells, Epstein-Barr virus transformant cells reactive with B serum-type Pseudomonas aeruginosa, the objective human-human hybridoma (FERM P-2268) is prepared. n COPYRIGHT: (C)1990,JPO&Japio
priorityDate 1989-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505939
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405821
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID141614
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154497143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403646
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID141614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439501

Total number of triples: 37.